Single-dose and fractionated irradiation of four human lung cancer cell lines in vitro.

Four established human lung cancer cell lines were exposed to single-dose irradiation. The survival curves of 2 small cell lung carcinomas (SCLC) were characterized by a limited capacity for repair with small and moderate shoulders with extrapolation numbers (n) of 1.05 and 1.60 respectively. Two non-small cell lung carcinoma (NSCLC) cell lines, one squamous cell (SQCLC) and one large cell (LCLC) had large shoulders with n-values of 73 and 15 respectively. The radiosensitivity when measured as D0 did not, however, differ as much from cell line to cell line, with values from 1.22 to 1.65. The surviving fraction after 2 Gy (SF2) was 0.24 and 0.42 respectively in the SCLC cell lines and 0.90 and 0.88 respectively in the NSCLC cell lines. Fractionated irradiation delivered according to 3 different schedules was also investigated. All the schedules delivered a total dose of 10 Gy in 5 days and were applied in 1, 2, and 5 Gy dose fractions respectively. Survival followed the pattern found after single-dose irradiation; it was lowest in the SCLC cell line with the lowest SF and highest in the two NSCLC cell lines. In the SCLC cell lines all schedules were approximately equally efficient. In the LCLC and in the SQCLC cell lines, the 5 Gy schedule killed more cells than the 1 and 2 Gy schedules. The results indicate that the size of the shoulder of the survival curve is essential when choosing the most tumoricidal fractionation schedule.

[1]  J. Bergh,et al.  A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four‐drug chemotherapy regimens , 1988, Cancer.

[2]  E. Rofstad,et al.  Radiation sensitivity in vitro of cells isolated from human tumor surgical specimens. , 1987, Cancer research.

[3]  Iannuzzi Mc,et al.  Small cell lung cancer. , 1986 .

[4]  M Tubiana,et al.  Klaas Breur Medal lecture 1985. The growth and progression of human tumors: implications for management strategy. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  H. Hansen,et al.  Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up. , 1986, British Journal of Cancer.

[6]  A. Gregor,et al.  Radiation studies on multicellular tumour spheroids derived from human neuroblastoma: absence of sparing effect of dose fractionation. , 1986, European journal of cancer & clinical oncology.

[7]  J. Peacock,et al.  The acute in vitro and in vivo radiosensitivity of human lung tumour lines. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  E. Rofstad,et al.  Radiation response of multicellular spheroids initiated from five human melanoma xenograft lines. Relationship to the radioresponsiveness in vivo. , 1986, The British journal of radiology.

[9]  J. Bergh,et al.  Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

[10]  R. Wittes,et al.  Increased survival with high‐dose multifield radiotherapy and intensive chemotherapy in limited small cell carcinoma of the lung , 1985, Cancer.

[11]  R. Arriagada,et al.  Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease. , 1985, International journal of radiation oncology, biology, physics.

[12]  G. Steel,et al.  The radioresponsiveness of human tumours and the initial slope of the cell survival curve. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  S. H. Wilson,et al.  Heterogeneity in the radiation survival curves and biochemical properties of human lung cancer cell lines. , 1984, Journal of the National Cancer Institute.

[14]  K. Kerr,et al.  Actual growth rate and tumour cell proliferation in human pulmonary neoplasms. , 1984, British Journal of Cancer.

[15]  S. Dische,et al.  Primary tumor control after radiotherapy for carcinoma of the bronchus. , 1984, International journal of radiation oncology, biology, physics.

[16]  S. Dische,et al.  The relationship between tumor response and survival following radiotherapy for carcinoma of the bronchus. , 1984, International journal of radiation oncology, biology, physics.

[17]  T. Kinsella,et al.  In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. , 1983, Cancer research.

[18]  J. Carlsson,et al.  Radiation sensitivity of human histiocytic lymphomas in vitro. , 1983, Acta radiologica. Oncology.

[19]  J. Bergh,et al.  Establishment and characterization of two neoplastic cell lines (U-1285 and U-1568) derived from small cell carcinoma of the lung. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

[20]  V. Courtenay,et al.  In vitro cellular radiosensitivity of human malignant melanoma. , 1982, International journal of radiation oncology, biology, physics.

[21]  J. Dewyngaert,et al.  Differential responses to x-irradiation of subpopulations of two heterogeneous human carcinomas in vitro. , 1982, Cancer research.

[22]  S. Baylin,et al.  Relationships between neuroendocrine differentiation and sensitivity to gamma-radiation in culture line OH-1 of human small cell lung carcinoma. , 1982, Cancer research.

[23]  H. Katz.  The results of different fractionation schemes in the palliative irradiation of metastatic melanoma. , 1981, International journal of radiation oncology, biology, physics.

[24]  B. Fertil,et al.  Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. , 1981, International journal of radiation oncology, biology, physics.

[25]  A. Dritschilo,et al.  Radiation therapy of malignant melanomas: An evaluation of clinically used fractionation schemes , 1979, Cancer.

[26]  J. Carlsson,et al.  Radiation effects on cultured human lymphoid cells. Analysis using the growth extrapolation method. , 1981, Acta radiologica. Oncology.

[27]  S Kramer,et al.  A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non‐oat‐cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group , 1980, Cancer.

[28]  J. Cox,et al.  Dose-time relationships and the local control of small cell carcinoma of the lung. , 1978, Radiology.

[29]  V. Courtenay,et al.  In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. , 1978, Cancer research.

[30]  T. Okamoto,et al.  A new in vitro cell line established from human oat cell carcinoma of the lung. , 1977, Cancer research.

[31]  R. Carey,et al.  Small cell anaplastic carcinoma of lung. Reappraisal of current management , 1976, Cancer.

[32]  W. Fox,et al.  Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. , 1973, Lancet.

[33]  B. Littbrand.  Multiplication of tumor cells in vitro after oxic or anoxic exposure to roentgen radiation. , 1970, Acta radiologica: therapy, physics, biology.

[34]  R. Rapp,et al.  The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. , 1968, Radiology.